Wednesday, November 09, 2005

ILMN

Illumina Inc. to conduct large scale genotyping for UK based research groups studying molescular basis of colorectal cancer. Keep this stock on your trading radar.

Budd Foxx

0 Comments:

Post a Comment

<< Home